HRP20100640T1 - Postupak proizvodnje rekombinantnog poliklonskog proteina - Google Patents
Postupak proizvodnje rekombinantnog poliklonskog proteina Download PDFInfo
- Publication number
- HRP20100640T1 HRP20100640T1 HR20100640T HRP20100640T HRP20100640T1 HR P20100640 T1 HRP20100640 T1 HR P20100640T1 HR 20100640 T HR20100640 T HR 20100640T HR P20100640 T HRP20100640 T HR P20100640T HR P20100640 T1 HRP20100640 T1 HR P20100640T1
- Authority
- HR
- Croatia
- Prior art keywords
- cells
- polyclonal
- protein
- cell line
- expression
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract 30
- 102000004169 proteins and genes Human genes 0.000 title claims abstract 29
- 238000000034 method Methods 0.000 title claims abstract 20
- 238000004519 manufacturing process Methods 0.000 title claims abstract 6
- 150000007523 nucleic acids Chemical group 0.000 claims abstract 5
- 238000001890 transfection Methods 0.000 claims abstract 3
- 239000013598 vector Substances 0.000 claims abstract 2
- 210000004027 cell Anatomy 0.000 claims 43
- 239000013604 expression vector Substances 0.000 claims 11
- 239000003550 marker Substances 0.000 claims 7
- 229920001184 polypeptide Polymers 0.000 claims 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims 4
- 210000004962 mammalian cell Anatomy 0.000 claims 3
- 108091023040 Transcription factor Proteins 0.000 claims 2
- 102000040945 Transcription factor Human genes 0.000 claims 2
- 210000000349 chromosome Anatomy 0.000 claims 2
- 210000003527 eukaryotic cell Anatomy 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 230000010354 integration Effects 0.000 claims 2
- 108020004707 nucleic acids Proteins 0.000 claims 2
- 102000039446 nucleic acids Human genes 0.000 claims 2
- 108091026890 Coding region Proteins 0.000 claims 1
- 241000699802 Cricetulus griseus Species 0.000 claims 1
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 1
- 230000010261 cell growth Effects 0.000 claims 1
- 238000010367 cloning Methods 0.000 claims 1
- 210000002950 fibroblast Anatomy 0.000 claims 1
- 238000001943 fluorescence-activated cell sorting Methods 0.000 claims 1
- 230000012010 growth Effects 0.000 claims 1
- 210000005260 human cell Anatomy 0.000 claims 1
- 201000000050 myeloid neoplasm Diseases 0.000 claims 1
- 210000001672 ovary Anatomy 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 230000035899 viability Effects 0.000 claims 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 239000012228 culture supernatant Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Non-Volatile Memory (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200700764 | 2007-05-25 | ||
| US92470807P | 2007-05-29 | 2007-05-29 | |
| DKPA200701292 | 2007-09-07 | ||
| US96000207P | 2007-09-11 | 2007-09-11 | |
| PCT/DK2008/050116 WO2008145133A2 (en) | 2007-05-25 | 2008-05-21 | Method for manufacturing a recombinant polyclonal protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20100640T1 true HRP20100640T1 (hr) | 2010-12-31 |
Family
ID=39739965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20100640T HRP20100640T1 (hr) | 2007-05-25 | 2010-11-24 | Postupak proizvodnje rekombinantnog poliklonskog proteina |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7910332B2 (es) |
| EP (1) | EP2152872B1 (es) |
| JP (2) | JP5941616B2 (es) |
| KR (1) | KR101555658B1 (es) |
| CN (1) | CN101688204B (es) |
| AT (1) | ATE481483T1 (es) |
| AU (1) | AU2008255383B2 (es) |
| BR (1) | BRPI0812091A2 (es) |
| CA (1) | CA2683800C (es) |
| CY (1) | CY1110939T1 (es) |
| DE (1) | DE602008002593D1 (es) |
| DK (1) | DK2152872T3 (es) |
| HK (1) | HK1134519A1 (es) |
| HR (1) | HRP20100640T1 (es) |
| IL (1) | IL201395A (es) |
| MX (1) | MX2009012526A (es) |
| NZ (1) | NZ581316A (es) |
| PL (1) | PL2152872T3 (es) |
| PT (1) | PT2152872E (es) |
| SI (1) | SI2152872T1 (es) |
| TW (1) | TW200902548A (es) |
| WO (1) | WO2008145133A2 (es) |
| ZA (1) | ZA200908021B (es) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0406678A (pt) | 2003-01-07 | 2005-12-20 | Symphogen As | Método para produzir proteìnas policlonais recombinantes |
| EP2121920B1 (en) * | 2007-03-01 | 2011-08-24 | Symphogen A/S | Method for cloning cognate antibodies |
| ATE481483T1 (de) * | 2007-05-25 | 2010-10-15 | Symphogen As | Verfahren zur herstellung eines rekombinanten polyklonalen proteins |
| BRPI0817079A2 (pt) * | 2007-09-07 | 2016-10-11 | Symphogen As | processos para fabricação recombinante de anticorpos anti-rsv |
| NZ601353A (en) * | 2008-02-01 | 2014-06-27 | Chromocell Corp | Cell lines and methods for making and using them |
| EP2098536A1 (en) | 2008-03-05 | 2009-09-09 | 4-Antibody AG | Isolation and identification of antigen- or ligand-specific binding proteins |
| SG189793A1 (en) * | 2008-04-23 | 2013-05-31 | Symphogen As | Methods for manufacturing a polyclonal protein |
| CA2726289A1 (en) * | 2008-05-28 | 2009-12-23 | Bayer Healthcare Llc | Methods and compositions for production of recombinant protein in hbx-expressing mammalian cells |
| WO2010022738A1 (en) * | 2008-08-29 | 2010-03-04 | Symphogen A/S | Method for cloning avian-derived antibodies |
| US8551733B2 (en) | 2009-02-09 | 2013-10-08 | Morphosys Ag | Production of oligoclonal mixtures of immunoglobulins in single cells |
| CA2816520C (en) | 2010-11-01 | 2017-11-21 | Symphogen A/S | Anti-her3 antibodies and compositions |
| AU2011329872B2 (en) | 2010-11-16 | 2017-04-13 | Excelimmune, Inc. | Methods for producing recombinant proteins |
| CN102558353A (zh) * | 2011-12-09 | 2012-07-11 | 上海应用技术学院 | 一种大肠杆菌NrfA基因表达蛋白多克隆抗体及其制备方法 |
| GB2502127A (en) | 2012-05-17 | 2013-11-20 | Kymab Ltd | Multivalent antibodies and in vivo methods for their production |
| CN104428318B (zh) | 2012-05-02 | 2018-09-25 | 西福根有限公司 | 人源化泛her抗体组合物 |
| JP2016514091A (ja) | 2013-02-08 | 2016-05-19 | ミスフォールディング ダイアグノスティクス， インコーポレイテッド | トランスサイレチン抗体およびその使用 |
| IL250902B (en) | 2014-09-16 | 2022-08-01 | Symphogen As | Anti-met antibodies and preparations |
| US20170044608A1 (en) * | 2015-07-17 | 2017-02-16 | Allele Biotechnology & Pharmaceuticals, Inc. | Methods of selecting antibodies and antibody fragments |
| KR20180096793A (ko) * | 2016-01-14 | 2018-08-29 | 안톤 바우어 | 생산 세포주를 제조하는 방법 |
| WO2018073393A2 (en) | 2016-10-19 | 2018-04-26 | Cellectis | Tal-effector nuclease (talen) -modified allogenic cells suitable for therapy |
| EA201992350A1 (ru) | 2017-04-05 | 2020-03-23 | Симфоген А/С | Комбинированные лекарственные средства, нацеленные на pd-1, tim-3 и lag-3 |
| CN112513074A (zh) | 2018-06-22 | 2021-03-16 | 健玛保 | 生产两种或更多种不同抗体的受控混合物的方法 |
| CN109988751A (zh) * | 2019-01-15 | 2019-07-09 | 济宁学院 | 一种用于制备抗egfr全人源化单克隆抗体的细胞株构建方法 |
| WO2020223573A2 (en) * | 2019-04-30 | 2020-11-05 | Gigagen, Inc. | Recombinant polyclonal proteins and methods of use thereof |
| US20220344000A1 (en) * | 2019-09-27 | 2022-10-27 | Glaxosmithkline Intellectual Property Development Limited | Method of predicting production stability of clonal cell lines |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0530216A4 (en) | 1990-04-19 | 1993-06-30 | Medimmune, Inc. | Administration of monoclonal antibodies against respiratory viruses |
| GB9022543D0 (en) * | 1990-10-17 | 1990-11-28 | Wellcome Found | Antibody production |
| US6111166A (en) | 1994-09-19 | 2000-08-29 | Medarex, Incorporated | Transgenic mice expressing human Fcα and β receptors |
| GB9703369D0 (en) | 1997-02-18 | 1997-04-09 | Lindqvist Bjorn H | Process |
| WO2001094571A1 (fr) * | 2000-06-08 | 2001-12-13 | Mitsubishi Pharma Corporation | Vecteur d'expression permettant le criblage de cellules a haute expression de proteine de recombinaison, transformant a haute expression de proteine de recombinaison, et leur utilisation |
| US6849259B2 (en) | 2000-06-16 | 2005-02-01 | Symphogen A/S | Polyclonal antibody composition for treating allergy |
| DK2314629T4 (da) * | 2002-07-18 | 2023-02-06 | Merus Nv | Rekombinant produktion af blandinger af antistoffer |
| AU2003283995A1 (en) | 2002-09-30 | 2004-04-19 | Protein Design Labs, Inc. | Efficient generation of stable expression cell lines through the use of scorable homeostatic reporter genes |
| CN100383244C (zh) * | 2003-01-07 | 2008-04-23 | 西福根有限公司 | 用于生产重组多克隆蛋白质的方法 |
| US20060275766A1 (en) | 2003-01-07 | 2006-12-07 | Haurum John S | Method for manufacturing recombinant polyclonal proteins |
| BRPI0406678A (pt) * | 2003-01-07 | 2005-12-20 | Symphogen As | Método para produzir proteìnas policlonais recombinantes |
| TWI333977B (en) | 2003-09-18 | 2010-12-01 | Symphogen As | Method for linking sequences of interest |
| DE602005016818D1 (de) * | 2004-07-20 | 2009-11-05 | Symphogen As | Verfahren zur charakterisierung einer polyklonalen zellinie |
| CA2574062A1 (en) * | 2004-07-20 | 2006-01-26 | Symphogen A/S | Anti-rhesus d recombinant polyclonal antibody and methods of manufacture |
| EP1966241A2 (en) | 2005-12-05 | 2008-09-10 | Symphogen A/S | Anti-orthopoxvirus recombinant polyclonal antibody |
| JP2009528828A (ja) | 2006-03-06 | 2009-08-13 | シムフォゲン・アクティーゼルスカブ | 消化器多核体ウイルス感染症の治療のための組み換えポリクローナル抗体 |
| ATE481483T1 (de) * | 2007-05-25 | 2010-10-15 | Symphogen As | Verfahren zur herstellung eines rekombinanten polyklonalen proteins |
-
2008
- 2008-05-21 AT AT08748815T patent/ATE481483T1/de active
- 2008-05-21 EP EP08748815A patent/EP2152872B1/en not_active Not-in-force
- 2008-05-21 MX MX2009012526A patent/MX2009012526A/es active IP Right Grant
- 2008-05-21 SI SI200830107T patent/SI2152872T1/sl unknown
- 2008-05-21 CN CN2008800174383A patent/CN101688204B/zh not_active Expired - Fee Related
- 2008-05-21 WO PCT/DK2008/050116 patent/WO2008145133A2/en active Application Filing
- 2008-05-21 AU AU2008255383A patent/AU2008255383B2/en not_active Ceased
- 2008-05-21 JP JP2010509679A patent/JP5941616B2/ja not_active Expired - Fee Related
- 2008-05-21 KR KR1020097027038A patent/KR101555658B1/ko active IP Right Grant
- 2008-05-21 BR BRPI0812091-9A2A patent/BRPI0812091A2/pt not_active Application Discontinuation
- 2008-05-21 PT PT08748815T patent/PT2152872E/pt unknown
- 2008-05-21 DE DE602008002593T patent/DE602008002593D1/de active Active
- 2008-05-21 PL PL08748815T patent/PL2152872T3/pl unknown
- 2008-05-21 NZ NZ581316A patent/NZ581316A/en not_active IP Right Cessation
- 2008-05-21 CA CA2683800A patent/CA2683800C/en not_active Expired - Fee Related
- 2008-05-21 DK DK08748815.1T patent/DK2152872T3/da active
- 2008-05-23 TW TW097119118A patent/TW200902548A/zh unknown
- 2008-05-23 US US12/153,809 patent/US7910332B2/en not_active Expired - Fee Related
-
2009
- 2009-10-11 IL IL201395A patent/IL201395A/en active IP Right Grant
- 2009-11-13 ZA ZA2009/08021A patent/ZA200908021B/en unknown
-
2010
- 2010-03-09 HK HK10102454.3A patent/HK1134519A1/xx not_active IP Right Cessation
- 2010-11-24 CY CY20101101058T patent/CY1110939T1/el unknown
- 2010-11-24 HR HR20100640T patent/HRP20100640T1/hr unknown
-
2014
- 2014-09-19 JP JP2014191912A patent/JP2015037411A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR101555658B1 (ko) | 2015-09-24 |
| MX2009012526A (es) | 2009-12-09 |
| EP2152872A2 (en) | 2010-02-17 |
| WO2008145133A3 (en) | 2009-02-05 |
| JP2015037411A (ja) | 2015-02-26 |
| US7910332B2 (en) | 2011-03-22 |
| CN101688204B (zh) | 2013-07-03 |
| DE602008002593D1 (de) | 2010-10-28 |
| PT2152872E (pt) | 2010-11-17 |
| KR20100017923A (ko) | 2010-02-16 |
| JP2011504721A (ja) | 2011-02-17 |
| HK1134519A1 (en) | 2010-04-30 |
| ATE481483T1 (de) | 2010-10-15 |
| WO2008145133A2 (en) | 2008-12-04 |
| AU2008255383A1 (en) | 2008-12-04 |
| IL201395A (en) | 2015-09-24 |
| CA2683800C (en) | 2015-03-17 |
| EP2152872B1 (en) | 2010-09-15 |
| CY1110939T1 (el) | 2015-06-10 |
| BRPI0812091A2 (pt) | 2014-10-14 |
| SI2152872T1 (sl) | 2011-01-31 |
| ZA200908021B (en) | 2010-11-24 |
| AU2008255383B2 (en) | 2012-11-01 |
| US20090111142A1 (en) | 2009-04-30 |
| JP5941616B2 (ja) | 2016-06-29 |
| CN101688204A (zh) | 2010-03-31 |
| IL201395A0 (en) | 2011-08-01 |
| TW200902548A (en) | 2009-01-16 |
| NZ581316A (en) | 2012-02-24 |
| PL2152872T3 (pl) | 2011-03-31 |
| CA2683800A1 (en) | 2008-12-04 |
| DK2152872T3 (da) | 2010-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20100640T1 (hr) | Postupak proizvodnje rekombinantnog poliklonskog proteina | |
| JP2011504721A5 (es) | ||
| JP7103603B2 (ja) | Ｃｈ３ドメインに基づくヘテロダイマー分子、その調製方法及び用途 | |
| CN104640985B (zh) | 特异结合性或功能性蛋白的转座介导鉴定 | |
| Bollin et al. | Design of Experiment in CHO and HEK transient transfection condition optimization | |
| CN104718296B (zh) | 包含嵌合巨细胞病毒启动子和增强子序列的表达载体 | |
| JP2011518790A5 (es) | ||
| RU2010113510A (ru) | Способы рекомбинантной продукции антител против респираторно-цинцитиального вируса (rsv) | |
| KR20100014724A (ko) | 숙주 세포에서 재조합 단백질의 발현을 증강시키기 위한 재조합 발현 벡터 요소(ｒＥＶＥ) | |
| JP6683598B2 (ja) | 安定なトランスフェクトされた細胞を生成するための方法および組成物 | |
| US10329594B1 (en) | Cell lines for high level production of protein-based pharmaceuticals | |
| JP2020509763A5 (es) | ||
| NZ723624A (en) | Expression constructs and methods for selecting host cells expressing polypeptides | |
| US20240115608A1 (en) | Immune receptors with synthetic co-stimulatory domains | |
| JP7179828B2 (ja) | 安定産生細胞株の作製のための選択マーカーとしての成長因子受容体の恒常的活性型変異体の使用 | |
| CN107109435A (zh) | 用于细胞转染和蛋白生产的新型选择性标记物 | |
| JP2020202840A (ja) | 真核細胞においてポリペプチドを発現させるための発現構築物及び方法 | |
| CN109705225B (zh) | 一种抗人caix抗原的嵌合抗原受体及其应用 | |
| US20150118754A1 (en) | Stable expression system for eukaryotic cells | |
| US11649449B2 (en) | Hybrid cell lines for high level production of a target protein | |
| RU2009148332A (ru) | Способ получения рекомбинантного поликлонального белка | |
| WO2024068995A1 (en) | Novel transposase system | |
| CN108191979B (zh) | 一种荧光互补检测人趋化因子生物学活性的方法 | |
| CN103339255A (zh) | 蛋白质的生产方法 | |
| WO2011015918A2 (en) | Vectors and compounds for expression of recombinant cetuximab |